Zacks Investment Research on MSN
Novartis' ianalumab wins breakthrough therapy tag for Sjogren's disease
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the ...
In addition to PH, columnist Jolie Lizana faces a possible scleroderma diagnosis, as coexisting conditions continue to ...
Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...
Scleroderma is an autoimmune condition that causes the skin to become tight and hard. This can change facial appearance, such as the mouth becoming smaller, and affect internal organs. With ...
Objectives (1) To assess the risk of haematological malignancies in individuals with systemic sclerosis (SSc) compared with individuals without SSc; (2) to explore how the risk varies across groups ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Immune-mediated vascular ...
Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international ...
Several factors were associated with increased pain among patients with systemic sclerosis, including the pain type, pain location, and disease subtype. Nearly all patients with systemic sclerosis ...
Abstract: The field of flexible devices is experiencing rapid growth in various fields, including healtcare, in order to improve currently inadequate diagnostic methods. Systemic Sclerosis (SSc), a ...
ABSTRACT: Objective: Study of severe visceral damage in systemic scleroderma in the rheumatology Department of CHU de Cocody. Patients and Methods: We conducted a retrospective descriptive study of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果